Imaging and radiotherapy for recurrent prostate cancer: An evolutionary partnership

Radiother Oncol. 2018 Nov;129(2):387-388. doi: 10.1016/j.radonc.2018.09.016. Epub 2018 Oct 15.

Authors

Julia R Murray¹, Klaus Kopka², Ali Afshar-Oromieh³

Affiliations

¹ The Royal Marsden NHS Foundation Trust, London, UK.
² Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany.
³ Department of Nuclear Medicine, Bern University Hospital, Switzerland; Department of Nuclear Medicine, Heidelberg University Hospital, Germany.

PMID: 30336957
DOI: 10.1016/j.radonc.2018.09.016

No abstract available

Publication types

Comment

MeSH terms

Australia
Humans
Male
Neoplasm Recurrence, Local
New Zealand
Prostatic Neoplasms*
Radiation Oncology*